Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Melanoma 30Leukemia, Lymphocytic, Chronic, B-Cell 28Leukemia 26Lymphoma 19Leukemia, Myeloid, Acute 18Myelodysplastic Syndromes 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Multiple Myeloma 15Neoplasm Metastasis 13Lymphoma, Follicular 12Skin Neoplasms 11Lymphoma, Mantle-Cell 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Hodgkin Disease 10Congenital Abnormalities 10Lymphoma, Non-Hodgkin 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Chronic-Phase 9Myeloproliferative Disorders 8Blast Crisis 8Anemia, Refractory, with Excess of Blasts 8Neoplasms, Plasma Cell 7Lymphoma, Large B-Cell, Diffuse 7Kidney Neoplasms 7Burkitt Lymphoma 7Primary Myelofibrosis 6Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Large-Cell, Immunoblastic 6

Interventions

fludarabine 2Cyclophosphamide 2fludarabine phosphate 1Magnetic Resonance Imaging 1Electrocardiography 1Echocardiography 1Diphenhydramine 1Blood Component Removal 1Antiemetics 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Philadelphia Chromosome × fludarabine phosphate × Clear all
NCT03448393 2025-06-04

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
54 enrolled 24 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡